Trials / Recruiting
RecruitingNCT06589362
Noninvasive Vagal Nerve Stimulation and Cognitive Rehabilitation
Enhancing Cognitive Rehabilitation After TBI Using Noninvasive Vagal Nerve Stimulation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Shirley Ryan AbilityLab · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the feasibility and preliminary efficacy of using transcutaneous auricular vagus nerve stimulation (tVNS) to enhance cognitive recovery in patients with mild-moderate traumatic brain injury (TBI).
Detailed description
Eligible participants will be invited to two sessions, 2-7 days apart. In each session, either active tVNS or sham stimulation will be administered while the participants are performing tasks of executive functions. The order of the sessions (tVNS vs Sham) will be counterbalanced across participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcutaneous auricular vagus active nerve stimulation | In the active stimulation, two electrodes are placed in the cymba conchae of one of the ears, an area thought to be exclusively innervated by the auricular branch of the vagus nerve. |
| DEVICE | Transcutaneous auricular vagus sham nerve stimulation | In the sham stimulation, the electrodes are placed on the tail of helix, which is free of vagal innervation. |
Timeline
- Start date
- 2024-09-07
- Primary completion
- 2026-06-01
- Completion
- 2026-08-01
- First posted
- 2024-09-19
- Last updated
- 2025-03-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06589362. Inclusion in this directory is not an endorsement.